Cyclo Therapeutics, Inc. (CYTH)
USD 0.63
(-4.58%)
USD 0.63
(-4.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.18 Million | -15.11 Million | -15 Million | -8.54 Million | -6.58 Million | -3.18 Million |
| Net Income | -20.05 Million | -15.45 Million | -14.28 Million | -8.94 Million | -7.53 Million | -4.25 Million |
| Depreciation & Amortization | 19.27 Thousand | 19.48 Thousand | 16.82 Thousand | 12.76 Thousand | 5681.00 | 10.12 Thousand |
| Deferred income taxes | -3.12 Million | - | - | -74.7 Thousand | - | -51.87 Thousand |
| Stock-based compensation | 736.91 Thousand | 513.56 Thousand | 470.87 Thousand | 271.3 Thousand | 436.69 Thousand | 83.42 Thousand |
| Change in working capital | 3.06 Million | -48.15 Thousand | -1.22 Million | 117.34 Thousand | 487.4 Thousand | 960.89 Thousand |
| Other non-cash items | 3.17 Million | -148.25 Thousand | 21.92 Thousand | 74.7 Thousand | 13.26 Thousand | 64.02 Thousand |
| Investing Cash Flow | -2420.00 | 38.17 Thousand | 14.82 Thousand | -14.04 Thousand | 36.13 Thousand | 32.94 Thousand |
| Investments in PPE | -2420.00 | -15.08 Thousand | -22.5 Thousand | -53.12 Thousand | -1324.00 | -2959.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2420.00 | 53.25 Thousand | 37.32 Thousand | 39.07 Thousand | 37.45 Thousand | 35.89 Thousand |
| Financing Cash Flow | 23.89 Million | 6778.00 | 18.75 Million | 18.61 Million | 7.11 Million | 4.1 Million |
| Debt repayment | - | -8159.00 | -6778.00 | -158.52 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 14.53 Million | 159.51 Thousand | 18.76 Million | 18.45 Million | 6.98 Million | 4.1 Million |
| Other Financing Activities | 9.35 Million | -144.57 Thousand | 18.75 Million | 317.04 Thousand | 130.06 Thousand | 4.1 Million |
| Accounts receivables | -67.38 Thousand | 427.85 Thousand | -444.02 Thousand | 72.41 Thousand | -63.38 Thousand | -23.18 Thousand |
| Accounts payables | 3.24 Million | -200.38 Thousand | -794.42 Thousand | 39.8 Thousand | 387.98 Thousand | 97.26 Thousand |
| Inventory | -52.78 Thousand | -27.05 Thousand | 10.47 Thousand | 4721.00 | 160.63 Thousand | 42.54 Thousand |
| Other working capital | -62.28 Thousand | -248.55 Thousand | -297.00 | 412.00 | 2162.00 | 844.27 Thousand |
| Cash at beginning of period | 1.54 Million | 16.61 Million | 12.84 Million | 2.78 Million | 2.21 Million | 1.27 Million |
| Cash at end of period | 9.24 Million | 1.54 Million | 16.61 Million | 12.84 Million | 2.78 Million | 2.21 Million |
| Capital Expenditure | -2420.00 | -15.08 Thousand | -22.5 Thousand | -53.12 Thousand | -1324.00 | -2959.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 7.7 Million | -15.06 Million | 3.76 Million | 10.06 Million | 566.3 Thousand | 946.43 Thousand |
| Free Cash Flow | -16.18 Million | -15.12 Million | -15.02 Million | -8.59 Million | -6.59 Million | -3.19 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.98 Million | -4.34 Million | -20.05 Million | -5.64 Million | -4.77 Million | -4.63 Million |
| Depreciation & Amortization | 2177.00 | 2177.00 | 19.27 Thousand | 4819.00 | 4819.00 | 4819.00 |
| Deferred income taxes | - | - | -3.12 Million | -61.76 Thousand | 126.24 Thousand | 1.45 Million |
| Stock-based compensation | 365.85 Thousand | 173.21 Thousand | 736.91 Thousand | 257.77 Thousand | 202.04 Thousand | 185.43 Thousand |
| Change in working capital | 1.14 Million | -2.11 Million | 3.06 Million | 1.03 Million | 523.29 Thousand | 967.49 Thousand |
| Other non-cash items | 44.79 Thousand | 1.78 Million | 3.17 Million | 114.68 Thousand | -126.24 Thousand | -1.45 Million |
| Investing Cash Flow | - | - | -2420.00 | -2420.00 | - | - |
| Investments in PPE | 3.84 Million | - | -2420.00 | -2420.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -2420.00 | -2420.00 | - | - |
| Financing Cash Flow | 1.97 Million | -69.28 Thousand | 23.89 Million | 11.74 Million | 5 Million | 3.4 Million |
| Debt repayment | -2 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 14.53 Million | 2.38 Million | 5 Million | 2.89 Million |
| Other Financing Activities | -25.23 Thousand | -69.28 Thousand | 9.35 Million | 9.35 Million | 1478.00 | 509.78 Thousand |
| Accounts receivables | -12.41 Thousand | 51.05 Thousand | -67.38 Thousand | 181.38 Thousand | -215.36 Thousand | 42.83 Thousand |
| Accounts payables | 955.19 Thousand | -1.56 Million | 3.24 Million | 121.78 Thousand | 711.62 Thousand | 916.65 Thousand |
| Inventory | 1502.00 | 11.82 Thousand | -52.78 Thousand | -97.51 Thousand | 26.88 Thousand | 7854.00 |
| Other working capital | 201.93 Thousand | -612.68 Thousand | -62.28 Thousand | 826.36 Thousand | 155.00 | 155.00 |
| Cash at beginning of period | 2.99 Million | 9.24 Million | 1.54 Million | 1.8 Million | 841.53 Thousand | 915.17 Thousand |
| Cash at end of period | 1.12 Million | 2.99 Million | 9.24 Million | 9.24 Million | 1.8 Million | 841.53 Thousand |
| Capital Expenditure | 3.84 Million | - | -2420.00 | -2420.00 | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.87 Million | -6.25 Million | 7.7 Million | 7.44 Million | 960.27 Thousand | -73.64 Thousand |
| Free Cash Flow | - | -6.18 Million | -16.18 Million | -4.29 Million | -4.04 Million | -3.47 Million |
2768
MUR
ENEA
RIO
NVMLF
600643